Regulatory Genome in a $6 million seed round led by Evolution Equity Partners, and joined by AlbionVC, Cambridge Enterprise, and Mastercard.

Regulatory Genome Development (RegGenome), a Cambridge, UK-based software company developing an aggregator of machine-readable regulatory content, announced the completion of a $6 million seed funding round.

The money was raised from investors led by Evolution Equity Partners, with participation from AlbionVC, Cambridge Enterprise, and Mastercard.

Richard Seewald, Managing Partner of Evolution Equity Partners, will join RegGenome’s board of directors.

RegGenome, founded in 2021 as a commercial spin-out from the University of Cambridge by CEO Richard Seewald, provides structured machine-readable regulatory content that is dynamic, granular, and interoperable, all powered by AI-based textual information extraction techniques.  This enables regulatory authorities to increase accessibility and dissemination of regulatory information and empowers organisations to deepen their regulatory intelligence and digitise their compliance and risk management processes.